Western blot assay further convinced that CXCL1 administration could elevate β-catenin protein expression levels in breast cancer cells while reversing the inhibitory effect of XPS on β-catenin protein expression in the co-cultured breast cancer cells (Figure 4D). This evidence concerns the gene CXCL1 and breast carcinoma.